ORA 14th Annual MeetingMore
The ORA 2015 Annual Meeting is being held May 22-24, 2015
REGISTRATION NOW OPEN! Book today as this event fills up quickly!
Update on Naproxen Suspension
Naproxen suspension has been relisted on Ontario Drug Benefits plan
Triple therapy for RA now approved for EAP
The Exceptional Access Program has decided to accept failure of 3 months of standard triple therapy (MTX 20 mg qweekly, Sulfasalzine 2 gm/day and Plaquenil 400 mg daily) to access EAP-funded biologic drugs. Full details can be accessed here.
It’s not too late to apply for a $5,000 Education Grant!
Enjoy a 1-minute friendly reminder video on this opportunity!
- View All News
Ontario Rheumatology Association Development and Education $5,000 Educational Grant
Now accepting applications!, Recipient may choose to attend EULAR 2015 in Rome or the 2015 ACR/ARHP 2015 Annual Meeting in San Francisco
Deadline: March 31, 2015
ORA Annual Meeting 2015
May 22-24, 2015, JW Marriott The Rosseau Muskoka Resort, Minett, Ontario
The ORA’s 14th Annual Meeting is being held May 22-24, 2015.
June 10-13, 2015, Rome, Italy
EULAR 2015 Rome, Italy. 10-13 June 2015. The next EULAR Annual European Congress of Rheumatology will take place from 10-13 June 2015 in Rome, Italy
- View All Events
Diamond: The Arthritis Society, Pfizer Canada Inc., Amgen Canada Inc., Janssen Inc., Celgene Inc., Bristol-Myers Squibb Canada, Roche Canada
Platinum: GlaxoSmithKline Inc., UCB Canada Inc., AstraZeneca Canada Inc., Abbvie., Takeda Canada Inc.